| Opening statement:Thank you for meeting with me to discuss anticoagulation in atrial fibrillation. |
| 1. Describe your practice and your patient population. |
| 2. Do you manage patients with atrial fibrillation frequently? |
| 3. When you consider whether or not to prescribe a medication for a patient, what factors influence your decision? |
| 4. When you management patients with atrial fibrillation, how do you go about deciding whether or not to anticoagulate? |
| 5. Please tell me what you know about the novel oral anticoagulants, also known as NOACs. |
| 6. What are your colleagues saying about NOACs? |
| 7. Can you describe an example of a patient for whom you prescribed a NOAC? |
| 8. What are your impressions regarding the benefits of NOACs compared to warfarin? |
| 9. What are your impressions regarding the risks of the NOACs compared to warfarin? |
| 10. Is there anything else about NOACs or atrial fibrillation you would like to share with me? |
